Giri Diagnostic Kits And Reagents Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 27416.70%
- Profit Growth -14839.80%
- Ebitda -16441.70%
- Net Worth -15396.50%
- Total Assets 9514.89%
About Giri Diagnostic Kits And Reagents
Giri Diagnostic Kits And Reagents Private Limited (GDKARPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 November 2010 and has a history of 14 years and three months. Its registered office is in Varanasi, Uttar Pradesh, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Brij Giri and Narendar Goswami serve as directors at the Company.
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51397UP2010PTC042461
- Company No.
042461
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Nov 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
What products or services does Giri Diagnostic Kits And Reagents Private Limited offer?
Giri Diagnostic Kits And Reagents Private Limited offers a wide range of products and services, including Rapid Test Kit, Diagnostic Test Kit, Clinical Reagents, Diagnostic Reagents, IVDs & Analyzers, Biochemistry Analyzer, Hematology Analyzers, Medical Laboratory Instruments, Pathology Lab Equipments, Sexual Wellness Products.
Who are the key members and board of directors at Giri Diagnostic Kits And Reagents?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Brij Giri  | Director | 02-Nov-2010 | Current |
Narendar Goswami  | Director | 18-Apr-2017 | Current |
Financial Performance of Giri Diagnostic Kits And Reagents.
Giri Diagnostic Kits And Reagents Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27416.7% increase. The company also saw a substantial fall in profitability, with a 14839.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15396.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Giri Diagnostic Kits And Reagents?
Unlock access to Giri Diagnostic Kits And Reagents's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Giri Diagnostic Kits And Reagents?
Unlock and access historical data on people associated with Giri Diagnostic Kits And Reagents, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Giri Diagnostic Kits And Reagents, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Giri Diagnostic Kits And Reagents's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
